Psychiatric alterations associated with huntington's disease

This study analyzes the psychiatric symptoms related to Huntington's disease, seeking a better understanding of its manifestations from a clinical-psychiatric approach. Through a descriptive study, data were collected from various sources, such as databases, scientific journals and specialized books. Huntington's disease is an autosomal dominant genetic disorder caused by CAG trinucleotide repeats in the HTT gene. Symptoms vary from case to case, usually appearing between the ages of 30 and 50, although it can manifest in adolescence as juvenile Huntington's disease. With motor and psychiatric manifestations, the diagnosis combines clinical, molecular and transcranial ultrasound evaluations. Currently, treatment is palliative, focused on mitigating symptoms

Authors

Institutions

Publication Details

Journal
Health Leadership and Quality of Life
Published
2024-12-30
DOI
https://doi.org/10.56294/hl2024.532
Primary Topic
Genetic Neurodegenerative Diseases
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Psychiatric alterations associated with huntington's disease

María Fernanda Morales Gómez de la Torre, Yesenia Esthefania Arellano-Oleas, Emily Dayana Guzmán-Ramos, Sandra Janneth Velásquez-Toro
2 links
Health Leadership and Quality of Life
Genetic Neurodegenerative Diseases
article

Psychiatric alterations associated with huntington's disease

María Fernanda Morales Gómez de la Torre, Yesenia Esthefania Arellano-Oleas, Emily Dayana Guzmán-Ramos, Sandra Janneth Velásquez-Toro
article en

Abstract

This study analyzes the psychiatric symptoms related to Huntington's disease, seeking a better understanding of its manifestations from a clinical-psychiatric approach. Through a descriptive study, data were collected from various sources, such as databases, scientific journals and specialized books. Huntington's disease is an autosomal dominant genetic disorder caused by CAG trinucleotide repeats in the HTT gene. Symptoms vary from case to case, usually appearing between the ages of 30 and 50, although it can manifest in adolescence as juvenile Huntington's disease. With motor and psychiatric manifestations, the diagnosis combines clinical, molecular and transcranial ultrasound evaluations. Currently, treatment is palliative, focused on mitigating symptoms

Health Leadership and Quality of LifeVol. 3
Universidad Regional Autónoma de Los Andes (EC)
Openalex Percentile: Top 73%
Genetic Neurodegenerative Diseases
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Psychiatric alterations associated with huntington's disease — María Fernanda Morales Gómez de la Torre, Yesenia Esthefania Arellano-Oleas, et al. · Health Leadership and Quality of Life (2024) | TGRS Research Map | TGRS